|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Monday
Elan (Tysabri) links with Archemix to develop MS drug:
"Drugmaker Elan will link up with Massachusetts-based biopharma company Archemix to develop therapeutic aptamers, or proteins that work like antibodies, to treat auto-immune diseases such as MS...." |